Rethinking the Customer Engagement Model in Japan for COVID-19 and Beyond L.E.K. Consulting Read more
Related Practice Life Sciences & Pharma Unlike many other markets in the world, Japan had until very recently been driven by ‘share-of-voice’, with market development and patient share being largely sensitive to sales activity. 01022024160132
Article Travel, Transport & Logistics Building Resilient and Sustainable Healthcare Supply Chains October 15, 2025
Special Report Life Sciences & Pharma On the Cusp of a Cure: Is Asia Pacific Ready for the Precision Era? (China) July 22, 2025
Case Study Life Sciences & Pharma Global Manufacturing Footprint Rationalization for a Leading Biopharmaceutical Company March 31, 2025 A leading biopharmaceutical company engaged L.E.K. Consulting to optimize its global manufacturing network. The client sought to reduce costs while…
Smart Chart Life Sciences & Pharma Unlocking Growth: Singapore's Role in Advancing Life Sciences and Medtech Innovations March 10, 2025
Executive Insights Digital Your AI Transformation Needs a Different Leadership Approach March 7, 2025
Published Articles Life Sciences & Pharma A Strategic Framework for Evaluating AI in Drug Discovery December 6, 2024